CD47 prevents Rac-mediated phagocytosis through Vav1 dephosphorylation

Area of Science:

• Immunology
• Cell Biology
• Molecular Biology

Background:

• CD47 is a cell surface protein that prevents phagocytosis by binding to SIRPα on myeloid cells.
• The downstream signaling pathway of SIRPα, which inhibits phagocytosis, remains incompletely understood.
• Understanding CD47-SIRPα interactions is crucial for developing cancer immunotherapies.

Purpose of the Study:

• To investigate the impact of CD47 on the kinetics and mechanisms of phagocytosis.
• To elucidate the specific molecular targets and signaling pathways involved in CD47-mediated inhibition of phagocytosis.
• To identify potential therapeutic targets for overcoming CD47-induced immune evasion.

Main Methods:

• Time-lapse imaging to analyze phagocytosis kinetics.
• Manipulation of GTPase activity (Rac2, Vav1) to assess their roles in phagocytosis.
• Western blotting to examine protein phosphorylation (Syk, Vav1) and recruitment to the phagocytic synapse.

Main Results:

• CD47-expressing targets were phagocytosed via a Rho-dependent 'sinking' mechanism, unlike IgG-opsonized targets primarily using Rac-dependent 'reaching'.
• Hyperactivation of Rac2 reversed CD47's suppressive effect, indicating CD47 inhibits Rac activation.
• CD47 specifically inhibited Vav1 phosphorylation, not its recruitment or Syk phosphorylation, and hyperactive Vav1 rendered macrophages insensitive to CD47.

Conclusions:

• CD47 inhibits phagocytosis by preventing Rac activation, a critical step mediated by Vav1 phosphorylation.
• Vav1 acts as a key downstream target of the CD47-SIRPα signaling axis.
• Targeting Vav1 phosphorylation may represent a novel strategy to overcome CD47-mediated immune suppression in cancer therapy.